Avalo Therapeutics
Manufacturing · Pennsylvania, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
1500 Liberty Ridge Dr Ste 321, Chesterbr...Phone Number
(410) 522-8707Website
www.avalotx.comRevenue
<$5 MillionStock Symbol
AVTXIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About Avalo Therapeutics
Avalo Therapeutics is a global biopharmaceutical enterprise focused on the development and commercialization of products in Rare Pediatric and Orphan diseases. Cerecor is located in Rockville, Maryland.Explore more
Avalo Therapeutics Org Chart
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Avalo Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Avalo Therapeutics
Product Launch: Get notified when Avalo Therapeutics launches new products
Funding: Get notified immidiatlly once Avalo Therapeutics has new funding data
Avalo Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Avalo Therapeutics is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Avalo Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Avalo Therapeutics recently announced quarterly report
Click to see if Avalo Therapeutics had a recent Job posting/layoffs
Recommended Actions
Find VP level buyers at Avalo Therapeutics
Find 2 more new buyers
Compare Similar Companies to Avalo Therapeutics
Compare insights from companies similar to Avalo Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Avalo Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Avalo Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Avalo Therapeutics.
Avalo Therapeutics financials insights
Gather financial insights about Avalo Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2015
Stock Offering
$26M
2020
Debt
$350K
2021
Multiple Rounds
$98.9M
Avalo Therapeutics Tech Stack
A closer look at the technologies used by Avalo Therapeutics
Most Recent Scoops
Person-Based
Pharmaceuticals, Clinical Operations
Person-Based
Events
Open Position
Open Position
Open Position
Avalo Therapeutics News & Media
Avalo Therapeutics to Participate in Upcoming Investor Conferences
WAYNE, Pa., Sept. 03, 2026 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (Nasdaq: AVTX), a clinical stage biotechnology company dedicated to developing therapeutics targeting the IL-1β pathway for immune-mediated inflammatory diseases, today announced that management will participate in the following investor conferences:Avalo Therapeutics Reports Second Quarter 2026 Financial Results and Recent Business Updates
WAYNE, Pa., Aug. 06, 2026 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (Nasdaq: AVTX), a clinical stage biotechnology company dedicated to developing therapeutics targeting the IL-1β pathway for immune-mediated inflammatory diseases, today announced business updates and financial results for the second quarter of 2026.Avalo Therapeutics to Participate in the BTIG Biotechnology Conference
WAYNE, Pa., July 22, 2026 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (Nasdaq: AVTX), a clinical stage biotechnology company fully dedicated to developing therapeutics targeting the IL-1β pathway for immune-mediated inflammatory diseases, today announced that Dr. Garry Neil, Chief Executive Officer of Avalo, will participate in the “Honing in on Hidradenitis” panel at the virtual BTIG Biotechnology Conference on Wednesday, July 29, 2026, at 10:30 am ET. Management will also host one-on-one inveAvalo Therapeutics to Participate in the Leerink Partners Therapeutics Forum
WAYNE, Pa., July 07, 2026 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (Nasdaq: AVTX), a clinical stage biotechnology company fully dedicated to developing therapeutics targeting the IL-1β pathway for immune-mediated inflammatory diseases, today announced that management will host one-on-one investor meetings during the Leerink Partners Therapeutics Forum on July 15, 2026, in Boston.
Read more news
Top Manufacturing Companies
Top companies in Australia by revenue
Frequently Asked Questions Regarding Avalo Therapeutics
Sign Up For FreeTo access detailed company insights
Avalo Therapeutics is a global biopharmaceutical enterprise focused on the development and commercialization of products in Rare Pediatric and Orphan diseases. Cerecor is located in Rockville, Maryland.... Read More
